Thyssenkrupp Braces for December 8 Report as Duisburg Delay Tests Green-Steel Credibility

Thyssenkrupp has set December 8, 2026 as the date for its 2025/2026 annual report, alongside an annual press briefing and an analyst and investor conference. For anyone weighing the stock, that date now carries more weight than the steady drip of shareholder disclosures that have drawn attention in recent weeks.

The reason is straightforward: the industrial logic of the group is under scrutiny, and the two most visible operational data points point in opposite directions. In Duisburg, the direct-reduction plant intended to produce climate-friendly steel will not start up until 2029, rather than the 2027 date originally envisaged. A company spokesperson attributed the slippage chiefly to the engineering phase. The later launch pushes back the point at which the facility can make its intended contribution, and it puts a premium on the reliability of the remaining project schedule.

Set against that, the subsidiary Thyssenkrupp Nucera commissioned a chlor-alkali plant for Kutch Chemical Industries on November 5. The facility, located in Padana in the Indian state of Gujarat, has an annual production capacity of 220,000 tonnes of caustic soda. A completed commissioning carries more substance as a valuation argument than a changed voting-rights percentage, though each project deserves its own assessment: in Duisburg the question is delivery, in India the milestone has been reached.

Big Banks, Different Bets

The shareholder filings tell their own story of divergent positioning. BlackRock disclosed a total voting position of 5.74%, of which 5.14% comes from shares and 0.60% from instruments; the relevant threshold was crossed on a Friday. Goldman Sachs reported 5.04% including instruments, split between just 0.56% in shares and 4.48% in instruments. Morgan Stanley, meanwhile, reported 4.1% including instruments on a Monday, down from 7.96% previously, with the threshold reached on November 2.

The composition matters more than the headline number. Looking only at the aggregate figure treats shares and instruments as equivalent, when in fact the disclosed positions differ markedly. BlackRock's exposure is weighted clearly toward equities, while Goldman Sachs sits predominantly in instruments. A higher reported total would only become a stronger argument for the stock if it came alongside convincing business figures.

Subsidy Secured, Hydrogen Tender Open

On the policy side, the amended funding notice for the tkH2Steel decarbonisation project at Thyssenkrupp Steel has become legally binding. The company used the occasion to announce a fresh hydrogen tender. Both developments firm up the framework around the green-steel programme even as its flagship plant's timetable has shifted.

Weighing it all up, caution prevails while the delayed Duisburg start weighs on the operational picture. The Nucera commissioning provides a positive counterweight. A more convincing overall assessment, however, requires Thyssenkrupp to pair such progress with robust business results — and that is precisely the yardstick to apply when the December 8 disclosures land.